Korean Shin Poong Pharm is testing its anti-malaria drug in Uganda to boost the fight against malaria.The vaccine venture reports 9,000 have been tested and that “the drug is very tolerable to most patients who took it.”
TrialSite News doesn’t have sufficient data to understand the scope of any safety data. Dr. Jimmy Opigo, programme manager at the National Malarial Control programme of the Ministry of Health reports the launch doesn’t mean they are stopping other treatment options. Mr. Opigo reported the sponsor has invested 17 years in the development of the product. They seek to encourage competitive alternatives.